Vestmark Advisory Solutions, Inc. Eli Lilly & CO Transaction History

Vestmark Advisory Solutions, Inc.

$2.21 Billion
Q2 2024

A detailed history of Vestmark Advisory Solutions, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 10,087 shares of LLY stock, worth $9.17 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

10,087

Previous 10,898 7.44%

Holding current value

$9.17 Million

Previous $8.48 Million 7.71%

% of portfolio

0.41%

Previous 0.39%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $587,869 - $737,231	-811 Reduced 7.44%	10,087 $9.13 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $183,582 - $245,606	-310 Reduced 2.77%	10,898 $8.48 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $249,465 - $294,086	-475 Reduced 4.07%	11,208 $6.53 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $3.73 Million - $5.15 Million	-8,588 Reduced 42.37%	11,683 $6.28 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $340,568 - $455,379	971 Added 5.03%	20,271 $9.51 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $677,484 - $795,672	2,181 Added 12.74%	19,300 $6.63 Million
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $171,707 - $200,073	534 Added 3.22%	17,119 $0
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $31,723 - $36,152	-107 Reduced 0.64%	16,585 $5.36 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $1.11 Million - $1.31 Million	3,988 Added 31.39%	16,692 $5.41 Million
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $128,375 - $159,538	547 Added 4.5%	12,704 $3.64 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $81,845 - $101,570	364 Added 3.09%	12,157 $3.36 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $414,170 - $509,694	1,869 Added 18.83%	11,793 $2.73 Million
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $106,885 - $138,255	592 Added 6.34%	9,924 $2.28 Million
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $96,127 - $124,441	585 Added 6.69%	9,332 $1.74 Million
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $63,794 - $84,416	489 Added 5.92%	8,747 $1.48 Million
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $225,325 - $260,629	-1,541 Reduced 15.73%	8,258 $1.22 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $17,325 - $20,850	127 Added 1.31%	9,799 $1.61 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $86,787 - $107,418	-729 Reduced 7.01%	9,672 $1.34 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $162,625 - $201,426	-1,521 Reduced 12.76%	10,401 $1.37 Million
Q3 2019 Nov 05, 2019	BUY	$106.79 - $116.16 $236,646 - $257,410	2,216 Added 22.83%	11,922 $1.33 Million
Q2 2019 Aug 20, 2019	SELL	$110.79 - $129.32 $158,872 - $185,444	-1,434 Reduced 12.87%	9,706 $1.08 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $1.24 Million - $1.46 Million	11,140 New	11,140 $1.45 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Account

Vestmark Advisory Solutions, Inc. Eli Lilly & CO Transaction History